The E2-RADIatE platform is an observational prospective multi-cohort study that collects real-world data of cancer patients treated with radiotherapy. It currently includes two cohorts, OligoCare and ReCare:
- OligoCare includes patients with oligometastatic cancer
- ReCare will include patients treated with high-dose re-irradiation
The development of cohort RP-2011 ReCare, is almost complete. Once the protocol is released (expected by September 2022), 26 sites will be able to enrol patients in the cohort after regulatory approvals and operational steps have been fulfilled.
Furthermore, in order to increase enrolment and data collection, we are exploring the interest in this cohort from sites already participating in OligoCare.
Thank you to all the participating centres that have so far contributed to Oligocare,
The EORTC 1822 study team